Exascale Labs Holdings Inc. (XLAB)
NASDAQ: XLAB · Real-Time Price · USD
4.710
+1.990 (73.16%)
At close: Oct 22, 2026, 4:00 PM EDT
4.410
-0.300 (-6.37%)
Pre-market: Oct 23, 2026, 4:47 AM EDT

Exascale Labs Holdings Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingJun '26 Jun '26 Jun '25 Jun '24
Revenue
14.8214.827.021.32
Revenue Growth
111.29%111.29%431.83%-
Gross Profit
2.422.421.110.06
Operating Income
-4.8-4.8-3.04-1.85
Net Income
-12.16-12.16-7.66-4.96

Revenue by Geography

Fiscal Year
FY 2025FY 2024
Period EndingJun '25 Jun '24
Singapore
2.480.26
United States of America
2.090.17
Canada
1.440.57
Hong Kong
0.60.16
United Kingdom
0.390.15
Others
0.010.01
Total
7.021.32

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingJun '26 Jun '26 Jun '25 Jun '24
Net Cash (Debt)
2.692.694.230.97
Net Cash Growth
-36.35%-36.35%336.43%-
Cash & Investments
2.692.694.230.97

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingJun '26 Jun '26 Jun '25 Jun '24
Operating Cash Flow
---1.01-0.56
Capital Expenditures
---0-0.03
Free Cash Flow
---1.01-0.59
Free Cash Flow Growth
----

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingJun '26 Jun '26 Jun '25 Jun '24
Gross Margin
16.31%16.31%15.75%4.21%
Operating Margin
-32.39%-32.39%-43.40%-139.93%
Pretax Margin
-82.05%-82.05%-109.18%-375.73%
Profit Margin
-82.05%-82.05%-109.18%-375.73%
FCF Margin
---14.44%-44.63%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingOct '26 Jun '26 Jun '25 Jun '24
PS Ratio
28.9820.10--